Cryoport Inc. (CYRX) Insider Trading

Last 12 months

Insiders sold $4.64M and bought nothing on the open market.

9% of the selling was scheduled in advance under 10b5-1 plans. Chief Financial Officer Robert Stefanovich sold $2.76M on Jun 4, 61% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2019.

Net open-market

−$4.64M

0 buys · 12 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 5

executives and directors

Last open-market buy

Nov 2019

Nov 12, 2019

Get an email when CYRX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 11	Jerrell Shelton President, CEO	Sold10b5-1 plan	28,800	$14.91	$429k	2.3%	Form 4
Jun 10 – 11	Edward J Zecchini Chief Digital and Tech Officer	SoldNo plan 2 parts	35,000	$14.50 average	$508k	24%	Form 4
Jun 8	Ramkumar Mandalam Director	SoldNo plan	23,214	$15.44	$358k	25%	Form 4
Jun 4	Robert Stefanovich Chief Financial Officer	SoldNo plan	169,427	$16.27	$2.76M	61%	Form 4
Mar 23	Robert Stefanovich Chief Financial Officer	SoldNo plan	1,094	$8.18	$9k	0.4%	Form 4
Mar 23	Jerrell Shelton President, CEO	SoldNo plan	2,894	$8.18	$24k	0.3%	Form 4
Mar 23	Mark W Sawicki Chief Scientific Officer	SoldNo plan	1,341	$8.18	$11k	1.3%	Form 4
Mar 16	Edward J Zecchini See Remarks	SoldNo plan	2,014	$8.00	$16k	1.8%	Form 4
Mar 16	Jerrell Shelton President, CEO	SoldNo plan	7,918	$8.00	$63k	0.7%	Form 4
Mar 16	Mark W Sawicki Chief Scientific Officer	SoldNo plan	3,235	$8.00	$26k	3.0%	Form 4
Mar 12 – 16	Robert Stefanovich Chief Financial Officer	SoldNo plan 2 parts	41,443	$7.78 average	$322k	13%	Form 4
Dec 10, 2025	Ramkumar Mandalam Director	SoldNo plan	11,570	$9.99	$116k	13%	Form 4
Sep 11, 2025	Robert J Hariri Director	SoldNo plan	25,000	$9.71	$243k	33%	Form 4
Aug 22, 2025	Robert J Hariri Director	SoldNo plan	5,000	$8.60	$43k	16%	Form 4
Aug 19, 2025	Robert Stefanovich Chief Financial Officer	SoldNo plan	9,300	$8.67	$81k	4.3%	Form 4
Jul 22, 2025	Ramkumar Mandalam Director	SoldNo plan	40,728	$7.24	$295k	31%	Form 4
Jun 24, 2025	Jerrell Shelton President, CEO	SoldNo plan	16,344	$7.06	$115k	1.7%	Form 4
Jun 24, 2025	Ramkumar Mandalam Director	SoldNo plan	13,321	$7.02	$94k	15%	Form 4
Jun 17, 2025 – Jun 20, 2025	Jerrell Shelton President, CEO	SoldNo plan 3 parts	339,720	$6.74 average	$2.29M	27%	Form 4
Jun 11, 2025 – Jun 13, 2025	Ramkumar Mandalam Director	SoldNo plan 3 parts	10,712	$7.04 average	$75k	14%	Form 4
Jun 10, 2025	Edward J Zecchini Chief Digital and Tech Officer	SoldNo plan	51,500	$6.85	$353k	36%	Form 4
Jun 9, 2025	Ramkumar Mandalam Director	SoldNo plan	5,622	$7.06	$40k	6.8%	Form 4
May 28, 2025	Robert J Hariri Director	SoldNo plan	12,500	$6.10	$76k	61%	Form 4
Mar 24, 2025	Mark W Sawicki Chief Scientific Officer	SoldNo plan	1,349	$6.94	$9k	1.6%	Form 4
Mar 24, 2025	Robert Stefanovich Chief Financial Officer	SoldNo plan	1,070	$6.94	$7k	0.6%	Form 4
Mar 24, 2025	Jerrell Shelton President, CEO	SoldNo plan	2,980	$6.94	$21k	0.4%	Form 4
Mar 17, 2025	Edward J Zecchini Chief Digital and Tech Officer	SoldNo plan	1,140	$6.29	$7k	1.7%	Form 4
Mar 17, 2025	Robert Stefanovich Chief Financial Officer	SoldNo plan	1,659	$6.29	$10k	0.9%	Form 4
Mar 17, 2025	Mark W Sawicki Chief Scientific Officer	SoldNo plan	2,092	$6.29	$13k	2.4%	Form 4
Mar 17, 2025	Jerrell Shelton President, CEO	SoldNo plan	4,620	$6.29	$29k	0.6%	Form 4
Mar 10, 2025	Mark W Sawicki Chief Scientific Officer	SoldNo plan	1,583	$4.88	$8k	2.0%	Form 4
Mar 10, 2025	Jerrell Shelton President, CEO	SoldNo plan	4,173	$4.88	$20k	0.6%	Form 4
Mar 10, 2025	Robert Stefanovich Chief Financial Officer	SoldNo plan	1,256	$4.88	$6k	0.7%	Form 4
Dec 2, 2024	Ramkumar Mandalam Director	Sold10b5-1 plan	7,369	$7.46	$55k	11%	Form 4
Nov 21, 2024 – Nov 22, 2024	Jerrell Shelton President, CEO	Sold10b5-1 plan 2 parts	72,817	$6.50 average	$473k	9.0%	Form 4
Nov 21, 2024	Robert J Hariri Director	SoldNo plan	2,500	$6.48	$16k	11%	Form 4
Nov 18, 2024 – Nov 20, 2024	Jerrell Shelton President, CEO	Sold10b5-1 plan 3 parts	150,000	$6.72 average	$1.01M	17%	Form 4

Aug 1110b5-1 plan
Jerrell Shelton
President, CEO · sold 28,800 at $14.91
$429k
2.3% of stake
Jun 10 – 11No plan
Edward J Zecchini
Chief Digital and Tech Officer · sold 35,000 at avg $14.50
$508k
24% of stake
Jun 8No plan
Ramkumar Mandalam
Director · sold 23,214 at $15.44
$358k
25% of stake
Jun 4No plan
Robert Stefanovich
Chief Financial Officer · sold 169,427 at $16.27
$2.76M
61% of stake
Mar 23No plan
Robert Stefanovich
Chief Financial Officer · sold 1,094 at $8.18
$9k
0.4% of stake
Mar 23No plan
Jerrell Shelton
President, CEO · sold 2,894 at $8.18
$24k
0.3% of stake
Mar 23No plan
Mark W Sawicki
Chief Scientific Officer · sold 1,341 at $8.18
$11k
1.3% of stake
Mar 16No plan
Edward J Zecchini
See Remarks · sold 2,014 at $8.00
$16k
1.8% of stake
Mar 16No plan
Jerrell Shelton
President, CEO · sold 7,918 at $8.00
$63k
0.7% of stake
Mar 16No plan
Mark W Sawicki
Chief Scientific Officer · sold 3,235 at $8.00
$26k
3.0% of stake
Mar 12 – 16No plan
Robert Stefanovich
Chief Financial Officer · sold 41,443 at avg $7.78
$322k
13% of stake
Dec 10, 2025No plan
Ramkumar Mandalam
Director · sold 11,570 at $9.99
$116k
13% of stake
Sep 11, 2025No plan
Robert J Hariri
Director · sold 25,000 at $9.71
$243k
33% of stake
Aug 22, 2025No plan
Robert J Hariri
Director · sold 5,000 at $8.60
$43k
16% of stake
Aug 19, 2025No plan
Robert Stefanovich
Chief Financial Officer · sold 9,300 at $8.67
$81k
4.3% of stake
Jul 22, 2025No plan
Ramkumar Mandalam
Director · sold 40,728 at $7.24
$295k
31% of stake
Jun 24, 2025No plan
Jerrell Shelton
President, CEO · sold 16,344 at $7.06
$115k
1.7% of stake
Jun 24, 2025No plan
Ramkumar Mandalam
Director · sold 13,321 at $7.02
$94k
15% of stake
Jun 17, 2025 – Jun 20, 2025No plan
Jerrell Shelton
President, CEO · sold 339,720 at avg $6.74
$2.29M
27% of stake
Jun 11, 2025 – Jun 13, 2025No plan
Ramkumar Mandalam
Director · sold 10,712 at avg $7.04
$75k
14% of stake
Jun 10, 2025No plan
Edward J Zecchini
Chief Digital and Tech Officer · sold 51,500 at $6.85
$353k
36% of stake
Jun 9, 2025No plan
Ramkumar Mandalam
Director · sold 5,622 at $7.06
$40k
6.8% of stake
May 28, 2025No plan
Robert J Hariri
Director · sold 12,500 at $6.10
$76k
61% of stake
Mar 24, 2025No plan
Mark W Sawicki
Chief Scientific Officer · sold 1,349 at $6.94
$9k
1.6% of stake
Mar 24, 2025No plan
Robert Stefanovich
Chief Financial Officer · sold 1,070 at $6.94
$7k
0.6% of stake
Mar 24, 2025No plan
Jerrell Shelton
President, CEO · sold 2,980 at $6.94
$21k
0.4% of stake
Mar 17, 2025No plan
Edward J Zecchini
Chief Digital and Tech Officer · sold 1,140 at $6.29
$7k
1.7% of stake
Mar 17, 2025No plan
Robert Stefanovich
Chief Financial Officer · sold 1,659 at $6.29
$10k
0.9% of stake
Mar 17, 2025No plan
Mark W Sawicki
Chief Scientific Officer · sold 2,092 at $6.29
$13k
2.4% of stake
Mar 17, 2025No plan
Jerrell Shelton
President, CEO · sold 4,620 at $6.29
$29k
0.6% of stake
Mar 10, 2025No plan
Mark W Sawicki
Chief Scientific Officer · sold 1,583 at $4.88
$8k
2.0% of stake
Mar 10, 2025No plan
Jerrell Shelton
President, CEO · sold 4,173 at $4.88
$20k
0.6% of stake
Mar 10, 2025No plan
Robert Stefanovich
Chief Financial Officer · sold 1,256 at $4.88
$6k
0.7% of stake
Dec 2, 202410b5-1 plan
Ramkumar Mandalam
Director · sold 7,369 at $7.46
$55k
11% of stake
Nov 21, 2024 – Nov 22, 202410b5-1 plan
Jerrell Shelton
President, CEO · sold 72,817 at avg $6.50
$473k
9.0% of stake
Nov 21, 2024No plan
Robert J Hariri
Director · sold 2,500 at $6.48
$16k
11% of stake
Nov 18, 2024 – Nov 20, 202410b5-1 plan
Jerrell Shelton
President, CEO · sold 150,000 at avg $6.72
$1.01M
17% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CYRX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Pharmaceutical Preparations

AMRNAmarin Corp PLC\Uk

URGNUrogen Pharma Ltd.

SLNOSoleno Therapeutics Inc

ABUSArbutus Biopharma Corporation

LFVNLifeVantage Corporation

MRVIMaravai Lifesciences Holdings Inc.

DAWNDay One Biopharmaceuticals, Inc.

MGNXMacrogenics Inc.

Spot a number that looks wrong? Check it in CYRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CYRX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.